The most consequential decisions in an eCOA strategy are made before the build begins. Instrument selection, recall period, endpoint hierarchy. Signant's clinical scientists engage at protocol stage, where scientific input has the most influence on study outcomes. Find out more: https://lnkd.in/gArZw6GY
Signant Health
Dezvoltare de software
Blue Bell, Pennsylvania 208.140 adepți
The Evidence Generation Company
Despre noi
For 25+ years, Signant Health has been pioneering solutions and methodologies that propel clinical research programs toward regulatory success. Our approach combines deep scientific expertise with comprehensive eClinical solutions, enabling study teams capture reliable evidence while making trials more manageable for sites and more meaningful for patients. From the smallest biotech running their first trial to global pharma sponsors and CROs launching pivotal, multinational studies, we're the partner who's been there before - supporting over 6,000 studies across 90+ countries, and contributing to 25% of recent FDA and EMA drug approvals. Visit www.signanthealth.com to discover how we deliver Proof at the Speed of Life™.
- Site web
-
https://www.signanthealth.com
Link extern pentru Signant Health
- Sector de activitate
- Dezvoltare de software
- Dimensiunea companiei
- 1.001 - 5.000 de angajați
- Sediu
- Blue Bell, Pennsylvania
- Tip
- Companie privată
- Înființată
- 2000
- Specializări
- clinical trial software, eCOA, eConsent, Patient Engagement, Rater Training, EDC, Digital Endpoints, RTSM/IRT, Clinical Supply Management, Scientific & Clinical Consulting, Clinical Data Quality și Protocol Design
Locații
Angajați la Signant Health
Actualizări
-
Rater Station reporting gives study teams comprehensive visibility into assessment activity, data integrity, rater quality and compliance to enable quality monitoring, study oversight and timely decision-making. Learn More: https://lnkd.in/eK-vxBS6
-
-
Signant's eCOA library has now surpassed 9,000 translations. For many studies, the translation work is already done. Read the full announcement: https://lnkd.in/e585hMX2
-
-
Demonstrating meaningful treatment benefit takes more than data collection. It takes multiple lines of evidence. What patients report and what clinicians observe are essential - they capture what matters most to patients and regulators. But clinical trials increasingly need more. Sensor-Enhanced eCOA (SEE) from Signant Health and Ametris combines patient-reported and clinician-rated data with continuous sensor-based measurement, designed together, deployed together, analyzed together. One endpoint strategy. Multiple lines of evidence. The complete patient picture. Learn More: https://lnkd.in/ge97yFCH #ClinicalTrials #eCOA #DigitalEndpoints
-
TrialMax® delivers faster eCOA without compromising on what can be built. Speed and full platform flexibility, together. Learn More: https://lnkd.in/dvJdFmQS
-
-
Rater Station®, the 20-year gold standard in electronic clinician ratings, is better than ever. Why? Because we asked sites what they wanted. Among them: a rater manager with 17 years at CNS sites, who got the latest look and said, "It solves everything I could think of in terms of making (Rater Station) more efficient." See what other sites are saying too: https://lnkd.in/ggvz5ZJJ
-
Signant Health a distribuit aceasta
Munich, we're on our way! Heading to ESC Congress 2026 (29-31 August) with my colleague Dr. Elias Ketiar for four days of late-breaking trials, new ESC Guidelines, and the conversations shaping the future of cardiovascular medicine. A highlight for our team while we're there: our colleague Dr Maria Visser and our collaborators at Leeds University have a poster being presented on a question we think matters a lot for how we measure trial outcomes - can quality-of-life change at 60 days post-discharge flag patients at the highest risk of readmission or death after heart failure hospitalization? The findings have real implications for how we think about outcome measurement in cardiovascular trials. Signant Health will be on the ground throughout - if you're attending and want to talk heart failure outcomes, eCOA, or trial design, drop a comment or send me a message. ESC U There? 👀🫀 #ESC2026 #Cardiology #ClinicalTrials #HeartFailure #ClinicalOutcomes #CardiovascularHealth #eCOA #SignantHealth #ESCUThere Elias Ketiar MD MD(Res) MRCP Maria Visser, Ph.D. Signant Health
-
-
Signant Health a distribuit aceasta
Come join an interesting discussion - we will be discussing the implications of the FDA/EMA joint AI principles and more.
The FDA and EMA have set the framework for AI in clinical trials. The tooling was already there. AI is resolving queries, screening patients, ranking sites, and drafting narratives, and the people accountable for quality and GCP oversight are being asked questions they don't yet have documented answers to. On Aug 6, we're mapping the framework before you have to defend it. Free 60-minute panel, moderated by Jessica Cordes (Senior Consultant, Clinical Excellence GmbH) with panelist Saubiya Kidwai (VP of Quality, Signant Health). More panelists to come. Thursday, August 6, 2026 · 11:00 AM ET Free and recorded. Register: https://lnkd.in/dHDufAKd #ClinicalTrials #ClinicalResearch #GCP #AIinPharma #RegulatoryAffairs #ClinicalQuality
-
Introducing Forecasting & Planning Assist™ - purpose-built agentic AI for clinical supply. “The supply experts remain in control throughout while AI handles the retrieval, the monitoring, and the execution of defined tasks. That combination of powerful AI and genuine expert oversight is what makes this approach both transformative and fit for a regulated environment." - Oliver Cunningham, Vice President of Product Management, Signant Health Forecasting & Planning Assist is now available. See what's possible when AI works alongside your supply experts. Read the Press Release: https://lnkd.in/dX8WfiNU
-
-
Tomorrow, four leading experts debate the endpoint questions obesity trials haven't answered yet. Register Now: https://lnkd.in/giph9hQp Mark Petrie Ildiko Lingvay Elias Ketiar MD MD(Res) MRCP Graham Ellis #ObesityTrials #ClinicalTrials #AOM #EndpointStrategy
-